- If approved by the U.S. FDA, ibrutinib will be the first therapy specifically approved for patients with marginal zone lymphoma (MZL), a slow-growing form of non-Hodgkin’s lymphoma, and the fifth new treatment indication for the medication “We continue …
AbbVie Announces Submission of a Supplemental New Drug Application for Ibrutinib (IMBRUVICA®) for Treatment of Marginal Zone Lymphoma
A cure for baldness could be on the horizon, after a new drug was found to restore hair growth in four weeks. The breakthrough offers hope to millions, specifically those people diagnosed with alopecia.
See more here:
Drug stimulates ‘regrowth of a FULL head of hair in just 4 months’
Alopecia areata - an autoimmune skin disease that causes patchy hair loss on the scalp, face, and body - affects as many as 6.8 million people in the United States. Researchers from Columbia University Medical Center have identified a promising therapy for …
Read the original here:
Alopecia: Hair growth restored with new drug
In a BSE filing today, Marksans Pharma said, “USFDA has granted approval for an abbreviated new drug application (ANDA) for loratadine liquid filled capsules 10 mg.” Loratadine liquid-filled capsules are therapeutically equivalent to the reference listed …
See original here:
Marksans Pharma gets USFDA clearance for allergy drug
Marksans Pharma shares surged as much as 12.5 per cent to hit intraday high of Rs 53.85 after the company announced that it has received US drug regulator’s approval for a medicine used in treatment of sneezing, runny nose and other allergies. The Mumbai …
See the rest here:
Marksans Pharma Surges On FDA Nod for New Drug
Fought urged everyone to report drug usage to the police. Officials also presented information on new drugs entering the area and about the danger meth production can cause to people. The presentation included photos from actual meth labs found locally and …
Seminar focuses on Mid-Ohio Valley drug problem
Doctors say, of the one million American’s with Parkinson’s, they believe half will develop PD psychosis.
Read the original post:
New treatment for Parkinson’s Disease Psychosis shows promise
He emphasized that being overly cautious has put the US and consumers at a disadvantage—with the average cost of a new drug today at $1 billion to get through the FDA. “So you gotta have pretty good pricing or have a whole lot of people that need it of …
Senator Tom Coburn on drug pricing and political gridlock
AUSTIN, Texas, Sept. 25, 2016 (GLOBE NEWSWIRE) — Austin area dog owners can now effectively address allergic skin conditions with Apoquel, from Zoetis, reports Dessau Vet Clinic.
Dessau Vet Clinic Offers Pet Allergy Treatment with the New Drug, Apoquel
NEW YORK – It didn’t take long to discover there was some hype behind the latest drug being touted as the great hope for Alzheimer’s disease. Earlier this summer, biotech giant Biogen staged a news conference extolling the merits of its experimental …
Could new drug prevent Alzheimer’s disease?